期刊文献+

宫颈癌患者血小板计数、纤维蛋白原、D-二聚体检测的临床意义 被引量:7

Clinical significance of platelet count,fibrinogen and D-dimer detection in patients with cervical cancer
原文传递
导出
摘要 目的探讨血小板计数、纤维蛋白原、D-二聚体检测对于宫颈癌患者的临床意义。方法检测87例宫颈癌患者(宫颈癌组)及66例宫颈良性病变患者(对照组)的血小板计数、纤维蛋白原、D-二聚体水平,分析三者的临床意义。结果宫颈癌组患者血小板计数、纤维蛋白原及D-二聚体均明显高于对照组[(274.22±82.32)×10^9/L比(238.82±74.97)×10^9/L、(3.03±0.59)玑比(2.67±0.45)g/L、(182.77±167.07)ng/L比(113.74±64.84)ng/L],差异均有统计学意义(P〈0.05)。国际妇产科协会分期Ⅱ期患者较Ⅰ期患者、肿瘤直径〉4cm患者较≤4cm患者血小板计数、纤维蛋白原、D-二聚体均明显升高[(296.66±94.30)×10^9/L比(251.26±60.86)×10^9/L、(3.22±0.67)g/L比(2.84±0.42)g/L、(238.61±213.29)ng/L比(125.63±62.96)ng/L,(299.14±81.33)×10^9/L比(257.44±79.39)×10^9/L、(3.20±0.67)g/L比(2.91±0.50)g/L、(281.29±223.33)ng/L比(116.46±51.69)ng/L],差异均有统计学意义(P〈0.05)。淋巴结转移阳性患者与阴性患者各指标比较差异均无统计学意义(P〉O.05)。结论宫颈癌患者血小板计数、纤维蛋白原、D-二聚体检测有助于宫颈癌的诊断、治疗及预后的判定。 Objective To study the clinical value of the platelet count (PC),fibrinogen (Fib) and D-dimer detection in patients with cervical cancer. Methods Eighty-seven patients with cervical cancer ( cervical cancer group ) and 66 patients with cervical benign lesion (control group ) were selected, the levels of PC, Fib and D-dimer were respectively determined to analyze the clinical significance of three factors. Results The PC,Fib and D-dimer in cervical cancer group were significantly higher than those in control group [ (274.22 ± 82.32) x 10^9/L vs. (238.82± 74.97) x 10^9/L, (3.03 ±0.59) g/L vs. (2.67 ± 0.45) g/L, ( 182.77 ± 167.07 ) ng/L vs. ( 113.74 +±64.84) ng/L, P 〈 0.05 ]. Patients with stage II and tumor volume 〉 4 cm were obviously higher than patients with stage I and tumor volume ≤4 cm in the PC, Fib and D-dimer [(296.66 ±94.30) x 10^9/L vs. (251.26 ±60.86) x 10^9/L, (3.22 ±0.67) g/L vs. (2.84 ±0.42) g/L, (238.61 ±213.29) ng/L vs. (125.63±62.96) ng/L, (299.14±81.33) x 10^9/L vs. (257.44 ±79.39) x 10^9/L,(3.20±0.67) g/L vs. (2.91 ±0.50) g/L,(281.29 ±223.33) ng/Lvs. (116.46±51.69) ng/L,P〈 0.05 ]. But there was no significant difference between lymph node metastasis positive patients and lymph node metastasis negative patients (P 〉 0.05). Conclusion The PC,Fib and D-dimer of patients with cervical cancer are helpful to clinical cervical cancer diagnosis, treatment and prognosis improvement.
作者 李琳 李佩玲
出处 《中国医师进修杂志》 2013年第15期12-14,共3页 Chinese Journal of Postgraduates of Medicine
关键词 宫颈肿瘤 血小板计数 纤维蛋白原 Uterine cervical neoplasms Platelet count Fibrinogen
  • 相关文献

参考文献9

  • 1刘晓丽.D-二聚体和血小板检测在妊娠子痫前期中的价值[J].中国医师进修杂志,2008,31(1):32-33. 被引量:6
  • 2Carrier M,le Gal G,Wells PS,et al. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med, 2008,149(5 ) : 323-333.
  • 3Ikeda M, Fumkawa H, Imamura H, et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol, 2002,9(3 ) : 287-291.
  • 4周毛婴.D-二聚体检测对妊娠高血压综合征患者胎盘早剥及产后出血的诊断及预测价值[J].中国医师进修杂志,2009,32(3):59-60. 被引量:5
  • 5陈文慧,王辰,张予辉,杨媛华,赵宏颖,张黎明.肺癌组织中凝血、纤溶成分过度表达对非小细胞肺癌预后的影响[J].中华医学杂志,2007,87(45):3228-3232. 被引量:10
  • 6Khosa F, Otero HJ,Prevedello LM,et al. Imaging presentation of venous thrombosis in patients with cancer. A JR Am J Roentgenol, 2010,194(4): 1099-1108.
  • 7Haas FJ, Schutgens RE, Biesma DIL An age-adapted approach for the use of D-dimers in the exclusion of deep venous thrombosis. Am J Hematol, 2009,84( 8 ) : 488-491.
  • 8Bradley CT,Brasel KJ,Miller JJ,et al. Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery. Ann Surg Oncol,2010,17( 1 ):31-39.
  • 9Pika B, Kremer IM, Rahoty P, et al. Thoughts about thromboembolic events prophylaxis in cancer patients. Magy Onkol, 2011,55 (3) : 164-169.

二级参考文献11

  • 1Ornstein DL, Zacharski LR, Memoli VA, et al. Coexisting macmphage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues. Cancer, 1991, 68 : 1061-1067.
  • 2Versteeg HH, Spek CA, Peppelenbosch MP, et al. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med, 2004, 10:6-11.
  • 3Nakasaki T, Wada H, Shigemori C, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hemoatol, 2002, 69: 247-254.
  • 4Ueno T, Toi M, Koike M, et al. Tissue factor expression in breast cancer tissue : its correlation with prognosis and plasma concentration. Br J Cancer, 2002, 83:164-170.
  • 5Yu JL, May L, Lhotak V, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood, 2005, 105:1734-1741
  • 6Lee KH, Bae SH, Lee JL, et al. Relationship between urokinasetype plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer. Oncology, 2004, 66:210-217.
  • 7Sehgal I, Foster TP, Francis J. Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis. Cancer Cell Int, 2006, 6:21.
  • 8Usher PA, Thomsen OF, Iversen P, et al. Expression of uPA, its receptor and PAI-1 in malignant and benign prostate tissue. Int J Cancer, 2005, 113:870-880.
  • 9Kaneko T, Konno H, Baba M, et al. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci, 2003, 94:43-49.
  • 10Taniguchi T, Kakkar AK, Tuddenham EG, et al. Enhanced expression of urokinase receptor induced through the tissue factor- factor Ⅶa pathway in human pancreatic cancer. Cancer Res, 1998, 58:4461-4467.

共引文献18

同被引文献77

  • 1丛玉隆,伍平,殷宗健,张立文.血浆凝血因子测定的影响因素探讨[J].中华医学检验杂志,1995,18(2):75-77. 被引量:31
  • 2陈化禹.D-二聚体及其测定方法探讨[J].实用医技杂志,2007,14(12):1567-1568. 被引量:17
  • 3Falanga A, Russo L, Verzeroli C. Mechanisms of thmmbosis in cancer[J]. Thromb Res, 2013,131 (Suppl 1 ) : S59-62.
  • 4Lin MS, Huang JX, Zhu J, et al. Elevation of platelet count in patients with colorectal cancer predicts tendcy to matastases and poor prognosis[J]. Hepatogastroenterolo gy,2012,59(118) :1687-1690.
  • 5Zheng S, Shen J ,Jiao Y, et al. Platelets and fibrinogen fa cilitate each other in protecting tumor cells from natural killer cytotoxicity[J]. Cancer Sci, 2009,100 ( 5 ) : 859-865.
  • 6Qiu J,Yu Y,Fu Y,et al. Preoperative plasma fibrinogen, platelet counted prognostic in epithelial ovarian cancer [J]. J Obstet Gynaecol Res,2012,38(4) :651-657.
  • 7Heras P, Hatzoulos A, Kritikos N, et al. Platelet count and tumor progression gastric cancer patient[J]. Stand J Gastroenterol, 2010,45 (7-8) : 1005- 1006.
  • 8Crasta J A, Premlatha TS, Krishnan SM, et al. Significance of preoperative thrombocytosis in epithelial ovarian cancer[J]. Indian J Pathol Mierobiol,2010,53(1) :54-56.
  • 9Patruno R, Arpalan N, Gadaleta CD, et al. VEGY concen- tration from plasma activated platelets rich correlated with microvascular density and grading in canine mast cell tumor spontaneous model[J]. J Cell Mol Med,2008, 13 (3) :555-561.
  • 10Buery D,Wenz F,Groden C,et al. Tumor platelet interac lion in solid tumors[J]. Cancer, 2012, 130(12): 2747- 2760.

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部